{
    "xml": "<topic id=\"PHP34444\" outputclass=\"drug\" rev=\"1.12\" type=\"drug\" namespace=\"/drugs/dimethyl-fumarate\" basename=\"dimethyl-fumarate\" title=\"DIMETHYL FUMARATE\">\n<title>DIMETHYL FUMARATE</title>\n<body>\n<data name=\"vtmid\">24056811000001108</data>\n<data name=\"classifications\">\n<data name=\"classification\">\n<data name=\"drugClassification\">\n<xref format=\"dita\" scope=\"local\" type=\"drugClassification\" href=\"#_125740553\" title=\"Fumaric acids\">Fumaric acids</xref>\n</data>\n</data>\n</data>\n<data name=\"primaryDomainOfEffect\">\n<data name=\"domainOfEffect\">  </data>\n</data>\n</body>\n<topic id=\"PHP60105\" outputclass=\"drugAction\" rev=\"1.8\" parent=\"/drugs/dimethyl-fumarate\">\n<title>Drug action</title>\n<body>\n<section>\n<sectiondiv>\n<p>Dimethyl fumarate has immunomodulatory and anti-inflammatory properties.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP59731\" outputclass=\"indicationsAndDose\" rev=\"1.14\" parent=\"/drugs/dimethyl-fumarate\">\n<title>Indications and dose</title>\n<body>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Treatment of adults with relapsing-remitting multiple sclerosis (initiated by a specialist)</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By mouth</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>120&#8239;mg twice daily for 7 days, then increased to 240&#8239;mg twice daily, for dose adjustment due to side effects&#8212;consult product literature.</p>\n</li>\n</ul>\n</section>\n</body>\n</topic>\n<topic id=\"PHP60611\" outputclass=\"cautions\" rev=\"1.15\" parent=\"/drugs/dimethyl-fumarate\">\n<title>Cautions</title>\n<body>\n<section outputclass=\"cautions\">\n<p>\n<ph outputclass=\"caution\">Reduced lymphocyte count</ph>; <ph outputclass=\"caution\">risk of serious infections (do not start treatment until resolved and consider suspending treatment if infection develops during treatment)</ph>; <ph outputclass=\"caution\">severe active gastro-intestinal disease</ph>\n</p>\n</section>\n</body>\n</topic>\n<topic id=\"PHP59152\" outputclass=\"sideEffects\" rev=\"1.17\" parent=\"/drugs/dimethyl-fumarate\">\n<title>Side-effects</title>\n<body>\n<section outputclass=\"generalSideEffects\">\n<sectiondiv outputclass=\"frequencies\">\n<sectiondiv outputclass=\"notKnown\">\n<p outputclass=\"title\">Frequency not known</p>\n<p outputclass=\"sideEffects\">\n<ph outputclass=\"sideEffect\">Abdominal pain</ph>; <ph outputclass=\"sideEffect\">burning sensation</ph>; <ph outputclass=\"sideEffect\">diarrhoea</ph>; <ph outputclass=\"sideEffect\">dyspepsia</ph>; <ph outputclass=\"sideEffect\">erythema</ph>; <ph outputclass=\"sideEffect\">flushing (may be severe and indicate hypersensitivity)</ph>; <ph outputclass=\"sideEffect\">gastritis</ph>; <ph outputclass=\"sideEffect\">gastroenteritis</ph>; <ph outputclass=\"sideEffect\">leucopenia</ph>; <ph outputclass=\"sideEffect\">lymphopenia</ph>; <ph outputclass=\"sideEffect\">nausea</ph>; <ph outputclass=\"sideEffect\">proteinuria</ph>; <ph outputclass=\"sideEffect\">pruritus</ph>; <ph outputclass=\"sideEffect\">rash</ph>; <ph outputclass=\"sideEffect\">vomiting</ph>\n</p>\n</sectiondiv>\n</sectiondiv>\n</section>\n<section outputclass=\"sideEffectsAdvice\">\n<title>Side-effects, further information</title>\n<sectiondiv>\n<p outputclass=\"title\">Progressive multifocal leukoencephalopathy (PML)</p>\n<p>Severe prolonged lymphopenia reported, and patients are exposed to a potential risk of PML. Treatment should be stopped immediately if PML is suspected.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP60509\" outputclass=\"conceptionAndContraception\" parent=\"/drugs/dimethyl-fumarate\">\n<title>Conception and contraception</title>\n<body>\n<section outputclass=\"generalInformation\">\n<sectiondiv>\n<p>Contraception required in women of child-bearing potential (consider non-hormonal methods).</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP59506\" outputclass=\"pregnancy\" parent=\"/drugs/dimethyl-fumarate\">\n<title>Pregnancy</title>\n<body>\n<section outputclass=\"generalInformation\">\n<sectiondiv>\n<p>Manufacturer advises avoid unless essential and potential benefit outweighs risk&#8212;toxicity in <i>animal</i> studies.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP60706\" outputclass=\"breastFeeding\" parent=\"/drugs/dimethyl-fumarate\">\n<title>Breast feeding</title>\n<body>\n<section outputclass=\"generalInformation\">\n<sectiondiv>\n<p>Manufacturer advises avoid.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP59857\" outputclass=\"hepaticImpairment\" parent=\"/drugs/dimethyl-fumarate\">\n<title>Hepatic impairment</title>\n<body>\n<section outputclass=\"generalInformation\">\n<sectiondiv>\n<p>Manufacturer advises caution in severe impairment.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP59356\" outputclass=\"renalImpairment\" parent=\"/drugs/dimethyl-fumarate\">\n<title>Renal impairment</title>\n<body>\n<section outputclass=\"generalInformation\">\n<sectiondiv>\n<p>Manufacturer advises caution in severe impairment.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP58702\" outputclass=\"monitoringRequirements\" parent=\"/drugs/dimethyl-fumarate\">\n<title>Monitoring requirements</title>\n<body>\n<section outputclass=\"monitoringOfPatientParameters\">\n<sectiondiv>\n<p>Monitor full blood count (including lymphocytes) before treatment (within 6 months before initiation), then every 6 to 12 months thereafter, and as clinically indicated. </p>\n<p>Monitor patient closely for features of progressive multifocal leukoencephalopathy (PML) (e.g. signs and symptoms of neurological dysfunction) and other opportunistic infections.</p>\n<p>Monitor renal and hepatic function before treatment, after 3 and 6 months of treatment, then every 6 to 12 months thereafter, and as clinically indicated.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP59434\" outputclass=\"patientAndCarerAdvice\" rev=\"1.11\" parent=\"/drugs/dimethyl-fumarate\">\n<title>Patient and carer advice</title>\n<body>\n<section outputclass=\"patientResources\">\n<sectiondiv>\n<p>Patient information leaflet should be provided.</p>\n</sectiondiv>\n</section>\n<section outputclass=\"generalPatientAdvice\">\n<sectiondiv>\n<p>Counselling is advised on progressive multifocal leukoencephalopathy.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP58427\" outputclass=\"nationalFunding\" rev=\"1.17\" parent=\"/drugs/dimethyl-fumarate\">\n<title>National funding/access decisions</title>\n<body>\r\n<section>\r\n<sectiondiv outputclass=\"niceTechnologyAppraisals\">\r\n<p outputclass=\"title\">NICE technology appraisals (TAs)</p>\r\n<sectiondiv outputclass=\"niceTechnologyAppraisal\">\r\n<p outputclass=\"fundingIdentifier\">NICE TA320</p>\r\n<sectiondiv>\r\n<p outputclass=\"title\">Dimethyl fumarate for treating relapsing-remitting multiple sclerosis (August 2014) </p>\r\n<p>Dimethyl fumarate is recommended for the treatment of active relapsing-remitting multiple sclerosis, only if:</p>\r\n<ul>\r\n<li>the patient does not have highly active or rapidly evolving severe relapsing-remitting multiple sclerosis <b>and</b>\r\n</li>\r\n<li>the manufacturer provides dimethyl fumarate with the discount agreed in the patient access scheme</li>\r\n</ul>\r\n<p>Patients currently receiving dimethyl fumarate whose disease does not meet the above criteria should be able to continue treatment until they and their clinician consider it appropriate to stop.</p>\n</sectiondiv>\n<xref format=\"html\" href=\"http://www.nice.org.uk/TA320\">www.nice.org.uk/TA320</xref>\n</sectiondiv>\n</sectiondiv>\r\n </section>\r\n\r\n</body>\n</topic>\n<topic id=\"PHP34444-medicinalForms\" outputclass=\"medicinalForms\" parent=\"/drugs/dimethyl-fumarate\">\n<title>Medicinal forms</title>\n<body>\n<section outputclass=\"licensingVariationStatement\">\n<p>There can be variation in the licensing of different medicines containing the same drug.</p>\n</section>\n</body>\n</topic>\n<parents>\n<xref format=\"dita\" scope=\"local\" type=\"drugs\" href=\"#drugs\" title=\"Drugs\" namespace=\"/drugs\">Drugs</xref>\n</parents>\n<children>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP94212\" title=\"Gastro-resistant capsule\" namespace=\"/drugs/dimethyl-fumarate/gastro-resistant-capsule\">Gastro-resistant capsule</xref>\n</children>\n<backlinks>\n<xref format=\"dita\" scope=\"local\" type=\"treatmentSummary\" href=\"#PHP107699\" namespace=\"/about/changes\" title=\"Changes\" count=\"1\" rel=\"backlink\">Changes</xref>\n<xref format=\"dita\" scope=\"local\" type=\"drugClassifications\" href=\"#PHP106980\" namespace=\"/drug-classifications\" title=\"Drug classifications\" count=\"1\" rel=\"backlink\">Drug classifications</xref>\n</backlinks>\n<links>\n<xref format=\"dita\" scope=\"local\" type=\"#drugs\" href=\"#drugs\" namespace=\"/drugs\" title=\"Drugs\" count=\"1\" rel=\"link\">Drugs</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP94212\" namespace=\"/drugs/dimethyl-fumarate/gastro-resistant-capsule\" title=\"Gastro-resistant capsule\" count=\"1\" rel=\"link\">Gastro-resistant capsule</xref>\n</links>\n</topic>",
    "id": "PHP34444",
    "outputclass": "drug",
    "rev": "1.12",
    "type": "drug",
    "namespace": "/drugs/dimethyl-fumarate",
    "basename": "dimethyl-fumarate",
    "title": "DIMETHYL FUMARATE",
    "vtmid": "24056811000001108",
    "drugClassification": [
        "Fumaric acids"
    ],
    "primaryDomainOfEffect": {
        "": {
            "domain": "",
            "therapeuticUses": {}
        }
    },
    "drugAction": {
        "drugAction": [
            {
                "type": "drugAction",
                "textContent": "Dimethyl fumarate has immunomodulatory and anti-inflammatory properties.",
                "html": "<p>Dimethyl fumarate has immunomodulatory and anti-inflammatory properties.</p>"
            }
        ]
    },
    "indicationsAndDoses": {
        "indicationAndDoseGroups": [
            {
                "indications": [
                    {
                        "textContent": "Treatment of adults with relapsing-remitting multiple sclerosis (initiated by a specialist)",
                        "html": "Treatment of adults with relapsing-remitting multiple sclerosis (initiated by a specialist)"
                    }
                ],
                "specificity": {
                    "routes": [
                        "mouth"
                    ],
                    "textContent": "By mouth",
                    "html": "By mouth"
                },
                "adult": [
                    {
                        "textContent": "120 mg twice daily for 7 days, then increased to 240 mg twice daily, for dose adjustment due to side effects&#8212;consult product literature.",
                        "html": "<p>120&#8239;mg twice daily for 7 days, then increased to 240&#8239;mg twice daily, for dose adjustment due to side effects&#8212;consult product literature.</p>"
                    }
                ]
            }
        ]
    },
    "cautions": {
        "cautions": [
            {
                "type": "cautions",
                "textContent": "Reduced lymphocyte count",
                "html": "Reduced lymphocyte count"
            },
            {
                "type": "cautions",
                "textContent": "risk of serious infections (do not start treatment until resolved and consider suspending treatment if infection develops during treatment)",
                "html": "risk of serious infections (do not start treatment until resolved and consider suspending treatment if infection develops during treatment)"
            },
            {
                "type": "cautions",
                "textContent": "severe active gastro-intestinal disease",
                "html": "severe active gastro-intestinal disease"
            }
        ]
    },
    "sideEffects": {
        "general": {
            "frequencies": {
                "notKnown": [
                    {
                        "type": "notKnown",
                        "textContent": "Abdominal pain",
                        "html": "Abdominal pain",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "burning sensation",
                        "html": "burning sensation",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "diarrhoea",
                        "html": "diarrhoea",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "dyspepsia",
                        "html": "dyspepsia",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "erythema",
                        "html": "erythema",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "flushing (may be severe and indicate hypersensitivity)",
                        "html": "flushing (may be severe and indicate hypersensitivity)",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "gastritis",
                        "html": "gastritis",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "gastroenteritis",
                        "html": "gastroenteritis",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "leucopenia",
                        "html": "leucopenia",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "lymphopenia",
                        "html": "lymphopenia",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "nausea",
                        "html": "nausea",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "proteinuria",
                        "html": "proteinuria",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "pruritus",
                        "html": "pruritus",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "rash",
                        "html": "rash",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "vomiting",
                        "html": "vomiting",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    }
                ]
            }
        },
        "advice": [
            {
                "type": "advice",
                "title": "Progressive multifocal leukoencephalopathy (PML)",
                "textContent": "Severe prolonged lymphopenia reported, and patients are exposed to a potential risk of PML. Treatment should be stopped immediately if PML is suspected.",
                "html": "<p>Severe prolonged lymphopenia reported, and patients are exposed to a potential risk of PML. Treatment should be stopped immediately if PML is suspected.</p>"
            }
        ]
    },
    "conceptionAndContraception": {
        "generalInformation": [
            {
                "type": "generalInformation",
                "textContent": "Contraception required in women of child-bearing potential (consider non-hormonal methods).",
                "html": "<p>Contraception required in women of child-bearing potential (consider non-hormonal methods).</p>"
            }
        ]
    },
    "pregnancy": {
        "generalInformation": [
            {
                "type": "generalInformation",
                "textContent": "Manufacturer advises avoid unless essential and potential benefit outweighs risk&#8212;toxicity in animal studies.",
                "html": "<p>Manufacturer advises avoid unless essential and potential benefit outweighs risk&#8212;toxicity in <i>animal</i> studies.</p>"
            }
        ]
    },
    "breastFeeding": {
        "generalInformation": [
            {
                "type": "generalInformation",
                "textContent": "Manufacturer advises avoid.",
                "html": "<p>Manufacturer advises avoid.</p>"
            }
        ]
    },
    "hepaticImpairment": {
        "generalInformation": [
            {
                "type": "generalInformation",
                "textContent": "Manufacturer advises caution in severe impairment.",
                "html": "<p>Manufacturer advises caution in severe impairment.</p>"
            }
        ]
    },
    "renalImpairment": {
        "generalInformation": [
            {
                "type": "generalInformation",
                "textContent": "Manufacturer advises caution in severe impairment.",
                "html": "<p>Manufacturer advises caution in severe impairment.</p>"
            }
        ]
    },
    "monitoringRequirements": {
        "patientParameters": [
            {
                "type": "patientParameters",
                "textContent": "Monitor full blood count (including lymphocytes) before treatment (within 6 months before initiation), then every 6 to 12 months thereafter, and as clinically indicated.\n\nMonitor patient closely for features of progressive multifocal leukoencephalopathy (PML) (e.g. signs and symptoms of neurological dysfunction) and other opportunistic infections.\n\nMonitor renal and hepatic function before treatment, after 3 and 6 months of treatment, then every 6 to 12 months thereafter, and as clinically indicated.",
                "html": "<p>Monitor full blood count (including lymphocytes) before treatment (within 6 months before initiation), then every 6 to 12 months thereafter, and as clinically indicated. </p><p>Monitor patient closely for features of progressive multifocal leukoencephalopathy (PML) (e.g. signs and symptoms of neurological dysfunction) and other opportunistic infections.</p><p>Monitor renal and hepatic function before treatment, after 3 and 6 months of treatment, then every 6 to 12 months thereafter, and as clinically indicated.</p>"
            }
        ]
    },
    "patientAndCarerAdvice": {
        "patientResources": [
            {
                "type": "patientResources",
                "textContent": "Patient information leaflet should be provided.",
                "html": "<p>Patient information leaflet should be provided.</p>"
            }
        ],
        "generalPatientAdvice": [
            {
                "type": "generalPatientAdvice",
                "textContent": "Counselling is advised on progressive multifocal leukoencephalopathy.",
                "html": "<p>Counselling is advised on progressive multifocal leukoencephalopathy.</p>"
            }
        ]
    },
    "nationalFunding": {
        "niceTechnologyAppraisals": [
            {
                "type": "niceTechnologyAppraisals",
                "references": [
                    {
                        "id": "http://www.nice.org.uk/TA320",
                        "label": "www.nice.org.uk/TA320"
                    }
                ],
                "fundingIdentifier": "NICE TA320",
                "textContent": "Dimethyl fumarate for treating relapsing-remitting multiple sclerosis (August 2014) Dimethyl fumarate is recommended for the treatment of active relapsing-remitting multiple sclerosis, only if: the patient does not have highly active or rapidly evolving severe relapsing-remitting multiple sclerosis and the manufacturer provides dimethyl fumarate with the discount agreed in the patient access scheme Patients currently receiving dimethyl fumarate whose disease does not meet the above criteria should be able to continue treatment until they and their clinician consider it appropriate to stop.\n\nwww.nice.org.uk/TA320",
                "html": "<p outputclass=\"title\">Dimethyl fumarate for treating relapsing-remitting multiple sclerosis (August 2014) </p> <p>Dimethyl fumarate is recommended for the treatment of active relapsing-remitting multiple sclerosis, only if:</p> <ul> <li>the patient does not have highly active or rapidly evolving severe relapsing-remitting multiple sclerosis <b>and</b> </li> <li>the manufacturer provides dimethyl fumarate with the discount agreed in the patient access scheme</li> </ul> <p>Patients currently receiving dimethyl fumarate whose disease does not meet the above criteria should be able to continue treatment until they and their clinician consider it appropriate to stop.</p><xref format=\"html\" href=\"http://www.nice.org.uk/TA320\">www.nice.org.uk/TA320</xref>"
            }
        ]
    },
    "medicinalForms": {
        "licensingVariationStatement": [
            {
                "type": "licensingVariationStatement",
                "textContent": "There can be variation in the licensing of different medicines containing the same drug.",
                "html": "<p>There can be variation in the licensing of different medicines containing the same drug.</p>"
            }
        ]
    },
    "children": {
        "medicinalForm": [
            {
                "id": "PHP94212",
                "label": "Gastro-resistant capsule",
                "type": "medicinalForm"
            }
        ]
    },
    "backlinks": {
        "treatmentSummary": [
            {
                "id": "PHP107699",
                "label": "Changes",
                "type": "treatmentSummary"
            }
        ],
        "drugClassifications": [
            {
                "id": "PHP106980",
                "label": "Drug classifications",
                "type": "drugClassifications"
            }
        ]
    },
    "links": {
        "#drugs": [
            {
                "id": "drugs",
                "label": "Drugs",
                "type": "#drugs"
            }
        ],
        "medicinalForm": [
            {
                "id": "PHP94212",
                "label": "Gastro-resistant capsule",
                "type": "medicinalForm"
            }
        ]
    }
}